Salim Syed
Stock Analyst at Mizuho Securities
(3.01)
# 2,648
Out of 5,060 analysts
1121
Total ratings
42.4%
Success rate
1.6%
Average return
Main Sectors:
Stocks Rated by Salim Syed
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PCVX Vaxcyte | Reiterated: Buy | $163 | $63.62 | +156.21% | 25 | Oct 5, 2026 | |
| ASMB Assembly Biosciences | Reiterated: Buy | $45 → $53 | $20.09 | +163.81% | 41 | Aug 31, 2026 | |
| ATRA Atara Biotherapeutics | Reiterated: Buy | $18 | $9.18 | +96.08% | 82 | Aug 31, 2026 | |
| BBIO BridgeBio Pharma | Reiterated: Buy | $96 → $110 | $66.39 | +65.69% | 108 | Aug 31, 2026 | |
| GILD Gilead Sciences | Reiterated: Buy | $170 | $156.19 | +8.84% | 112 | Aug 31, 2026 | |
| KURA Kura Oncology | Reiterated: Buy | $25 | $9.08 | +175.33% | 10 | Aug 31, 2026 | |
| AMGN Amgen | Reiterated: Hold | $303 → $352 | $432.49 | -18.61% | 172 | Aug 17, 2026 | |
| ELVN Enliven Therapeutics | Reiterated: Buy | $62 → $73 | $37.32 | +95.61% | 18 | Aug 17, 2026 | |
| IOVA Iovance Biotherapeutics | Reiterated: Buy | $10 → $11 | $13.62 | -19.24% | 6 | Aug 17, 2026 | |
| IPSC Century Therapeutics | Reiterated: Buy | $8 | $1.37 | +483.94% | 4 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $1.80 | +566.67% | 43 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $22.12 | +112.48% | 6 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $221 → $241 | $232.65 | +3.59% | 133 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $121 → $137 | $113.07 | +21.16% | 8 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $23 | $3.13 | +634.82% | 81 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 → $118 | $61.95 | +90.48% | 146 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $97 | $27.53 | +252.34% | 4 | Jun 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.60 | +525.00% | 6 | Jun 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 → $43 | $12.90 | +233.33% | 8 | Mar 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $1.79 | +346.93% | 2 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 | $49.25 | n/a | 23 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $145.95 | n/a | 2 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $22.85 | n/a | 2 | Nov 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $53 | $29.58 | n/a | 1 | May 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $4.49 | n/a | 1 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.99 | n/a | 73 | Jun 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 | $11.32 | n/a | 1 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $54.68 | n/a | 1 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $22.23 | n/a | 1 | Aug 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7.1 | $8.52 | n/a | 1 | Jul 2, 2019 |
Vaxcyte
Oct 5, 2026
Reiterated: Buy
Price Target: $163
Current: $63.62
Upside: +156.21%
Assembly Biosciences
Aug 31, 2026
Reiterated: Buy
Price Target: $45 → $53
Current: $20.09
Upside: +163.81%
Atara Biotherapeutics
Aug 31, 2026
Reiterated: Buy
Price Target: $18
Current: $9.18
Upside: +96.08%
BridgeBio Pharma
Aug 31, 2026
Reiterated: Buy
Price Target: $96 → $110
Current: $66.39
Upside: +65.69%
Gilead Sciences
Aug 31, 2026
Reiterated: Buy
Price Target: $170
Current: $156.19
Upside: +8.84%
Kura Oncology
Aug 31, 2026
Reiterated: Buy
Price Target: $25
Current: $9.08
Upside: +175.33%
Amgen
Aug 17, 2026
Reiterated: Hold
Price Target: $303 → $352
Current: $432.49
Upside: -18.61%
Enliven Therapeutics
Aug 17, 2026
Reiterated: Buy
Price Target: $62 → $73
Current: $37.32
Upside: +95.61%
Iovance Biotherapeutics
Aug 17, 2026
Reiterated: Buy
Price Target: $10 → $11
Current: $13.62
Upside: -19.24%
Century Therapeutics
Aug 17, 2026
Reiterated: Buy
Price Target: $8
Current: $1.37
Upside: +483.94%
Aug 17, 2026
Reiterated: Buy
Price Target: $12
Current: $1.80
Upside: +566.67%
Aug 5, 2026
Reiterated: Buy
Price Target: $47
Current: $22.12
Upside: +112.48%
Aug 3, 2026
Reiterated: Buy
Price Target: $221 → $241
Current: $232.65
Upside: +3.59%
Aug 3, 2026
Reiterated: Buy
Price Target: $121 → $137
Current: $113.07
Upside: +21.16%
Aug 3, 2026
Reiterated: Buy
Price Target: $27 → $23
Current: $3.13
Upside: +634.82%
Jun 23, 2026
Reiterated: Buy
Price Target: $100 → $118
Current: $61.95
Upside: +90.48%
Jun 23, 2026
Reiterated: Buy
Price Target: $97
Current: $27.53
Upside: +252.34%
Jun 10, 2026
Reiterated: Buy
Price Target: $10
Current: $1.60
Upside: +525.00%
Mar 30, 2026
Reiterated: Buy
Price Target: $45 → $43
Current: $12.90
Upside: +233.33%
Nov 14, 2025
Reiterated: Buy
Price Target: $8
Current: $1.79
Upside: +346.93%
May 20, 2025
Reiterated: Buy
Price Target: $85
Current: $49.25
Upside: n/a
Nov 22, 2024
Rated: Hold
Price Target: n/a
Current: $145.95
Upside: n/a
Nov 22, 2024
Rated: Hold
Price Target: n/a
Current: $22.85
Upside: n/a
May 28, 2024
Reiterated: Buy
Price Target: $53
Current: $29.58
Upside: n/a
Mar 25, 2024
Reiterated: Buy
Price Target: $25
Current: $4.49
Upside: n/a
Jun 16, 2023
Rated: Hold
Price Target: n/a
Current: $0.99
Upside: n/a
Mar 6, 2023
Reiterated: Buy
Price Target: $21
Current: $11.32
Upside: n/a
Nov 3, 2022
Reiterated: Buy
Price Target: $23
Current: $54.68
Upside: n/a
Aug 4, 2022
Reiterated: Buy
Price Target: $25
Current: $22.23
Upside: n/a
Jul 2, 2019
Reiterated: Buy
Price Target: $7.1
Current: $8.52
Upside: n/a